Original document(61 pages) Authorized document(63 pages) 中文版
    The invention is based on the discovery that compounds of Formula (I), are unexpectedly highly potent and selective inhibitors of the adenosine A1 receptor. Adenosine A1 antagonists can be useful in the prevention and/or treatment of numerous diseases, including cardiac and circulatory disorders, degenerative disorders of the central nervous system, respiratory disorders, and many diseases for which diuretic treatment is suitable. In one embodiment, the invention features a compound of formula (I).
Application Number
申请号
00816198 Application Date
申请日
2000.11.13
Title 名称 Adenosine receptor antagonists and methods of making and using the same
Publication Number
公开号
1399636 Publication Date
公开日
2003.02.26
Approval Pub. Date 2005.02.02 Granted Pub. Date 2005.02.02
International Classification 分类号 A61K31/505;A61K31/52;A61P9/00;C07D473/06
Applicant(s) Name
申请人
Biogen, Inc.
Address 地址
Inventor(s) Name 发明人 J.E. Dowling;C. Ensinger;G. Kumaravel et.al
Attorney & Agent 代理人 du jingyang
More information 更  多  信  息


 Related patents information
Google
Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.